Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:TCW Rumors Heat Up As July Ends Not Rated 5.0 Email Routing List Email & Route  Print Print
Tuesday, July 31, 2012

TCW Rumors Heat Up As July Ends

Reported by Neil Anderson, Managing Editor

The word in Los Angeles is that Carlyle Group is on the verge of signing a deal to buy TCW [profile]. Fundsters told MFWire that they expect Societe Generale to sign a deal this week, and one source said they'll announce the sale tomorrow.

Spokesmen for Carlyle and TCW both declined to comment for this story. MFWire could not immediately reach a SocGen spokesperson based in New York City.

Earlier this month Reuters reported that two other private equity firms had dropped out of the bidding. Carlyle is the only publicly-mentioned bidder remaining. On Friday, the wire service reported that SocGen's unions approved the TCW sale. Yet the report added that neither the price and the winning bidder were revealed at the meeting.

One insider told MFWire that the price is $700 million, all in Carlyle stock. That nearly matches the $350-million-for-51-percent pricing then-chief investment officer Jeff Gundlach offered SocGen back in September 2009, according to Gundlach's testimony in court last year. He made that offer prior to TCW's purchase of rival MetWest, announced in December 2009. 

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

5.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2020: Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly




©All rights reserved to InvestmentWires, Inc. 1997-2020
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use